 |
|
 |
Japanese owned biotech joins march into Cambridge clusterJapanese owned Heptares Therapeutics is relocating to the Cambridge life science cluster from its current base in Welwyn. |
 |
Former Novartis and Merck ace is Kymab’s first CMOAnbtibodies powerhouse Kymab has appointed immunologist Dr Sonia Quaratino as its first chief medical officer. Dr Quaratino (pictured) will manage the clinical development of the... |
 |
East of England springboard for new £500m medical fundLifeArc, the UK medical research charity previously known as MRC Technology, is investing up to £500 million in the next five years to generate, fund and champion innovations in... |
 |
Cambridge backs assault on battery tech marketCambridge University spin-out Echion Technologies is making great strides towards commercialising its lithium ion battery technology and is picking up accolades along the way. |
 |
Cyan earns extra $3.9m from Bangladesh dealCambridge UK CleanTech business CyanConnode has clinched a $3.9 million bonus from an extended contract in Bangladesh. |
 |
Consort Medical almost doubles profits and hikes dividendDrug and delivery device business Consort Medical plc almost doubled pre-tax profits to £21.9 million in the year to April 30 on revenues 6.2 per cent ahead at £294m. |
 |
Students use smart technology for space explorationSmart technology deployed by Milton Keynes-based Open University is set to prove out of this world for STEM students. |
 |
AF Group boosts turnover against backdrop of lower commodity pricesFarming powerbroker AF Group has reported continued growth with turnover increasing £3.3 million to £234.2m in the past 12 months. |
 |
Abzena revenues surge signals major expansion in the USA handsome spike in revenues layered on top of recent fundraising success is triggering significant expansion in the US for Cambridge life science business Abzena. |
Latest News
Submitted by Anonymous (not verified) on 21 June, 2017 - 11:54